Sphingolipid signalling: Molecular basis and role in TNF-α-induced cell death

Expert Reviews in Molecular Medicine

Volumn 4, Issue 28, 2002, Pages 1-15

  Malagarie Cazenave, Sophie ^a   Andrieu Abadie, Nathalie ^a   Ségui, Bruno ^a   Gouazé, Valérie ^a   Tardy, Claudine ^a   Cuvillier, Olivier ^a   Levade, Thierry ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SPHINGOLIPID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; CELL DEATH; CELL STRUCTURE; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DEATH; CELLULAR STRUCTURES; HUMANS; MODELS, BIOLOGICAL; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2442540272     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S146239940200546X     Document Type: Article

References (67)

1. Hengartner, M.O. (2000) The biochemistry of apoptosis. Nature 407, 770–776, PubMed: 20500222
2. Kolesnick, R.N. and Kronke, M. (1998) Regulation of ceramide production and apoptosis. Annu Rev Physiol 60, 643–665, PubMed: 98219171
3. Hannun, Y.A. and Luberto, C. (2000) Ceramide in the eukaryotic stress response. Trends Cell Biol 10, 73–80, PubMed: 20126821
4. Tracey, K.J. and Cerami, A. (1993) Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9, 317–343, PubMed: 94107574
5. Vandenabeele, P. et al. (1995) Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 5, 392–399
6. Wallach, D. et al. (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17, 331–367, PubMed: 99286814
7. Bodmer, J.L., Schneider, P. and Tschopp, J. (2002) The molecular architecture of the TNF superfamily. Trends Biochem Sci 27, 19–26, PubMed: 21655817
8. Karin, M. and Lin, A. (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3, 221–227, PubMed: 21864600
9. Hannun, Y.A., Luberto, C. and Argraves, K.M. (2001) Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40, 4893–4903, PubMed: 21203002
10. Levade, T. and Jaffrezou, J.P. (1999) Signalling sphingomyelinases: which, where, how and why? Biochim Biophys Acta 1438, 1–17, PubMed: 99233575
11. Levade, T. et al. (2001) Sphingolipid mediators in cardiovascular cell biology and pathology. Circ Res 89, 957–968, PubMed: 21573825
12. Kim, M.Y. et al. (1991) Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem 266, 484–489, PubMed: 91093169
13. Haimovitz-Friedman, A. et al. (1997) Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 186, 1831–1841, PubMed: 98044248
14. Yanaga, F. and Watson, S.P. (1992) Tumor necrosis factor alpha stimulates sphingomyelinase through the 55 kDa receptor in HL-60 cells. FEBS Lett 314, 297–300, PubMed: 93106172
15. Segui, B. et al. (2001) Involvement of FAN in TNF-induced apoptosis. J Clin Invest 108, 143–151, PubMed: 21329141
16. Schutze, S. et al. (1992) TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced ‘acidic’ sphingomyelin breakdown. Cell 71, 765–776, PubMed: 93046681
17. Linardic, C.M. and Hannun, Y.A. (1994) Identification of a distinct pool of sphingomyelin involved in the sphingomyelin cycle. J Biol Chem 269, 23530–23537, PubMed: 94375454
18. Andrieu, N., Salvayre, R. and Levade, T. (1996) Comparative study of the metabolic pools of sphingomyelin and phosphatidylcholine sensitive to tumor necrosis factor. Eur J Biochem 236, 738–745, PubMed: 96195688
19. Veldman, R.J. et al. (2001) A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. Biochem J 355, 859–868, PubMed: 21210962
20. Andrieu, N., Salvayre, R. and Levade, T. (1994) Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts. Biochem J 303, 341–345, PubMed: 95071227
21. Nix, M. and Stoffel, W. (2000) Perturbation of membrane microdomains reduces mitogenic signaling and increases susceptibility to apoptosis after T cell receptor stimulation. Cell Death Differ 7, 413–424, PubMed: 20261977
22. Lozano, J. et al. (2001) Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts. J Biol Chem 276, 442–448, PubMed: 20576386
23. Xu, J. et al. (1998) Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death. J Biol Chem 273, 16521–16526, PubMed: 98298174
24. Dbaibo, G.S. et al. (2001) Ceramide generation by two distinct pathways in tumor necrosis factor alpha-induced cell death. FEBS Lett 503, 7–12, PubMed: 21405472
25. Ohta, H. et al. (1994) A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-alpha in human neutrophils. FEBS Lett 355, 267–270, PubMed: 95080392
26. Krown, K.A. et al. (1996) Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98, 2854–2865, PubMed: 97136533
27. Nava, V.E. et al. (2000) Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res 60, 4468–4474, PubMed: 20424195
28. Cuvillier, O. et al. (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381, 800–803, PubMed: 96267009
29. Xia, P. et al. (1999) Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J Biol Chem 274, 34499–34505, PubMed: 20036602
30. Mathias, S, Pena, L.A. and Kolesnick, R.N. (1998) Signal transduction of stress via ceramide. Biochem J 335, 465–480, PubMed: 99013682
31. Obeid, L.M. et al. (1993) Programmed cell death induced by ceramide. Science 259, 1769–1771, PubMed: 93206124
32. Cuvillier, O., Edsall, L. and Spiegel, S. (2000) Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J Biol Chem 275, 15691–15700, PubMed: 20283592
33. Cuvillier, O. and Levade, T. (2001) Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. Blood 98, 2828–2836, PubMed: 21531325
34. Kuno, K. et al. (1994) Acid sphingomyelinase is not essential for the IL-1 and tumor necrosis factor receptor signaling pathway leading to NFkB activation. Int Immunol 6, 1269–1272, PubMed: 95071958
35. Gamard, C.J. et al. (1997) Selective involvement of ceramide in cytokine-induced apoptosis. Ceramide inhibits phorbol ester activation of nuclear factor kappaB. J Biol Chem 272, 16474–16481, PubMed: 97341187
36. Zumbansen, M. and Stoffel, W. (1997) Tumor necrosis factor alpha activates NF-kappaB in acid sphingomyelinase-deficient mouse embryonic fibroblasts. J Biol Chem 272, 10904–10909, PubMed: 97256818
37. Dbaibo, G.S. et al. (1997) Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J Exp Med 185, 481–490, PubMed: 97188781
38. Wright, S.C., Zheng, H. and Zhong, J. (1996) Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24). Faseb J 10, 325–332, PubMed: 96206085
39. Cai, Z. et al. (1997) Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-alpha-mediated cytotoxicity. J Biol Chem 272, 6918–6926, PubMed: 97207244
40. Bezombes, C. et al. (1998) Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833. Faseb J 12, 101–109, PubMed: 98099252
41. Schwandner, R. et al. (1998) TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J Biol Chem 273, 5916–5922, PubMed: 98157996
42. Wiegmann, K. et al. (1999) Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase. J Biol Chem 274, 5267–5270, PubMed: 99150300
43. Kreder, D. et al. (1999) Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. Embo J 18, 2472–2479, PubMed: 99246272
44. Adam-Klages, S. et al. (1996) FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86, 937–947, PubMed: 96404447
45. Jayadev, S. et al. (1997) Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. J Biol Chem 272, 17196–17203, PubMed: 97347536
46. Hayter, H.L. et al. (2001) TNFalpha-induced glutathione depletion lies downstream of cPLA(2) in L929 cells. FEBS Lett 507, 151–156, PubMed: 21541257
47. Liu, B. et al. (1998) Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem 273, 11313–11320, PubMed: 98225218
48. Burow, M.E. et al. (2000) Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. J Biol Chem 275, 9628–9635, PubMed: 20200460
49. El-Assaad, W. et al. (1998) Distinct sites of action of Bcl-2 and Bcl-xL in the ceramide pathway of apoptosis. Biochem J 336, 735–741, PubMed: 99059706
50. Xia, P. et al. (2002) Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling. J Biol Chem 277, 7996–8003, PubMed: 21864259
51. Beutler, B. and Bazzoni, F. (1998) TNF, apoptosis and autoimmunity: a common thread? Blood Cells Mol Dis 24, 216–230, PubMed: 98452326
52. McDermott, M.F. (2001) TNF and TNFR biology in health and disease. Cell Mol Biol (Noisy-le-grand) 47, 619–635, PubMed: 21392980
53. Eigler, A. et al. (1997) Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today 18, 487–492, PubMed: 98019990
54. Lee, D.M. and Weinblatt, M.E. (2001) Rheumatoid arthritis. Lancet 358, 903–911, PubMed: 21453528
55. Selzner, M. et al. (2001) Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 61, 1233–1240, PubMed: 21115863
56. Senchenkov, A., Litvak, D.A. and Cabot, M.C. (2001) Targeting ceramide metabolism-a strategy for overcoming drug resistance. J Natl Cancer Inst 93, 347–357, PubMed: 21136549
57. Morita, Y. et al. (2000) Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 6, 1109–1114, PubMed: 20473280
58. Hofmann, K. and Dixit, V.M. (1998) Ceramide in apoptosis-does it really matter? Trends Biochem Sci 23, 374–377, PubMed: 99027917
59. Dressler, K.A., Mathias, S. and Kolesnick, R.N. (1992) Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255, 1715–1718, PubMed: 92205354
60. Wiegmann, K. et al. (1994) Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78, 1005–1015, PubMed: 95007751
61. Bettaieb, A. et al. (1996) Opposite effects of tumor necrosis factor alpha on the sphingomyelin-ceramide pathway in two myeloid leukemia cell lines: role of transverse sphingomyelin distribution in the plasma membrane. Blood 88, 1465–1472, PubMed: 96329582
62. Coroneos, E. et al. (1995) Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation. J Biol Chem 270, 23305–23309, PubMed: 96007465
63. Bourteele, S. et al. (1998) Tumor necrosis factor induces ceramide oscillations and negatively controls sphingolipid synthases by caspases in apoptotic Kym-1 cells. J Biol Chem 273, 31245–31251, PubMed: 99030397
64. Singh, I. et al. (1998) Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem 273, 20354–20362, PubMed: 98352074
65. Scurlock, B. and Dawson, G. (1999) Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents: role of ceramide in apoptosis. J Neurosci Res 55, 514–522, PubMed: 20189953
66. Chae, H.J. et al. (2000) Dexamethasone suppresses tumor necrosis factor-alpha-induced apoptosis in osteoblasts: possible role for ceramide. Endocrinology 141, 2904–2913, PubMed: 20373887
67. Bulotta, S. et al. (2001) Activation of the endothelial nitric-oxide synthase by tumor necrosis factor-alpha. A novel feedback mechanism regulating cell death. J Biol Chem 276, 6529–6536, PubMed: 21125865